The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Roche affirms flu drug effectiveness amid resistance claims and rising demand
Roche has refuted claims that its flu drug, Xofluza, has lost effectiveness against certain influenza strains, asserting that it remains sensitive to viruses globally. Ongoing research in China, led by the National Center for Infectious Disease and professor Zhang Wenhong, is examining potential drug resistance. Despite Xofluza's patent protection, some Chinese companies are developing generic versions, with CSPC Pharmaceutical Group's generic tablets approved in 2022 but not yet available on the market.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.